Chen X - Search Results

1

CA-125 level as a prognostic indicator in type I and type II epithelial ovarian cancer.

Chen X, Zhang J, Cheng W, Chang DY, Huang J, Wang X, Jia L, Rosen DG, Zhang W, Yang D, Gershenson DM, Sood AK, Bast RC Jr, Liu J. Chen X, et al. Int J Gynecol Cancer. 2013 Jun;23(5):815-22. doi: 10.1097/IGC.0b013e31828f7a24. Int J Gynecol Cancer. 2013. PMID: 23669443 Free PMC article.

2

CA-125-indicated asymptomatic relapse confers survival benefit to ovarian cancer patients who underwent secondary cytoreduction surgery.

Wang F, Ye Y, Xu X, Zhou X, Wang J, Chen X. Wang F, et al. Among authors: chen x. J Ovarian Res. 2013 Feb 13;6(1):14. doi: 10.1186/1757-2215-6-14. J Ovarian Res. 2013. PMID: 23402322 Free PMC article.

3

Nadir CA-125 level as prognosis indicator of high-grade serous ovarian cancer.

Xu X, Wang Y, Wang F, Jia L, Zhou Y, Deng F, Qu J, Zhou B, Meng A, Fu B, Chen X, Qian Z, Wang J. Xu X, et al. Among authors: chen x. J Ovarian Res. 2013 Apr 25;6:31. doi: 10.1186/1757-2215-6-31. eCollection 2013. J Ovarian Res. 2013. PMID: 23618037 Free PMC article.

4

Cancer stem cells, epithelial-mesenchymal transition, and drug resistance in high-grade ovarian serous carcinoma.

Chen X, Zhang J, Zhang Z, Li H, Cheng W, Liu J. Chen X, et al. Hum Pathol. 2013 Nov;44(11):2373-84. doi: 10.1016/j.humpath.2013.05.001. Epub 2013 Jul 11. Hum Pathol. 2013. PMID: 23850493 Free PMC article. Review.

5

Age is associated with prognosis in serous ovarian carcinoma.

Deng F, Xu X, Lv M, Ren B, Wang Y, Guo W, Feng J, Chen X. Deng F, et al. Among authors: chen x. J Ovarian Res. 2017 Jun 12;10(1):36. doi: 10.1186/s13048-017-0331-6. J Ovarian Res. 2017. PMID: 28606125 Free PMC article.

6

Functional polymorphisms of the hOGG1 gene confer risk to type 2 epithelial ovarian cancer in Chinese.

Chen X, Liu X, Wang J, Guo W, Sun C, Cai Z, Wu Q, Xu X, Wang Y. Chen X, et al. Int J Gynecol Cancer. 2011 Nov;21(8):1407-13. doi: 10.1097/IGC.0b013e31823122c6. Int J Gynecol Cancer. 2011. PMID: 21997177

7

Secondary cytoreduction surgery improves prognosis in platinum-sensitive recurrent ovarian cancer.

Xu X, Chen X, Dai Z, Deng F, Qu J, Ni J. Xu X, et al. Among authors: chen x. J Exp Clin Cancer Res. 2013 Sep 2;32(1):61. doi: 10.1186/1756-9966-32-61. J Exp Clin Cancer Res. 2013. PMID: 24059600 Free PMC article.

8

SNAP23 promotes the malignant process of ovarian cancer.

Sun Q, Huang X, Zhang Q, Qu J, Shen Y, Wang X, Sun H, Wang J, Xu L, Chen X, Ren B. Sun Q, et al. Among authors: chen x. J Ovarian Res. 2016 Nov 17;9(1):80. doi: 10.1186/s13048-016-0289-9. J Ovarian Res. 2016. PMID: 27855700 Free PMC article.

9

Ascites regression following neoadjuvant chemotherapy in prediction of treatment outcome among stage IIIc to IV high-grade serous ovarian cancer.

Xu X, Deng F, Lv M, Ren B, Guo W, Chen X. Xu X, et al. Among authors: chen x. J Ovarian Res. 2016 Dec 2;9(1):85. doi: 10.1186/s13048-016-0294-z. J Ovarian Res. 2016. PMID: 27912779 Free PMC article.

10

The number of cycles of neoadjuvant chemotherapy is associated with prognosis of stage IIIc-IV high-grade serous ovarian cancer.

Xu X, Deng F, Lv M, Chen X. Xu X, et al. Among authors: chen x. Arch Gynecol Obstet. 2017 Feb;295(2):451-458. doi: 10.1007/s00404-016-4256-x. Epub 2016 Dec 3. Arch Gynecol Obstet. 2017. PMID: 27913927

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

118,263 results

Search Page

Filters